Articles related to Osprey Pharmaceuticals USA

Focus efforts and move quickly to ‘proof of relevancy’ milestone

August 31, 2009 - Conference: - Company:

Jack M. Anthony, CEO of Osprey Pharmaceuticals USA, has enjoyed a rich and varied career across a range of biotechnology start-ups thanks to a love of biology and a passion for dealmaking. He has concluded agreements valued over USD 3 billion to date.
Anthony will moderate a panel discussion at BioPharm America 2009 in San Francisco Read more »

Newsletter

Subscribe to partneringNEWS
An online journal for executives in the life sciences, partneringNEWS™ is focused on the people behind the deals. Putting a human face to a collaboration agreement gives business development professionals the ability to get behind the headlines.

Sign up today to the free newsletter and never miss any new content.